During the Miami Breast Cancer Conference, CURE discussed ADCs with Dr. Kevin Kalinsky. The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Cipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing ...
A phase III trial found that combining giredestrant with Pfizer’s Ibrance did not significantly slow disease progression compared with standard ...
Cipla USA has recalled over 400 cartons of Nilotinib Capsules used to treat blood cancers after they failed to meet specifications, according to the U.S. Food and Drug Administration, which classified ...
Cipla recalls over 400 cartons of Nilotinib cancer medication in the U.S. due to manufacturing specification issues, USFDA reports.
A copy of the poster is available on the Company’s website.
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...
Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...
Biocon Biologics is among the leading global suppliers of biosimilar insulins and has been expanding its portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results